港股異動 | 索信達控股漲8% 引入戰略性股東
格隆匯1月26日丨索信達控股(3680.HK)盤中漲8.48%,報6.65港元,總市值27億港元。索信達控股25日發佈公吿,董事會獲Mindas Touch(公司控股股東之一)吿知,其已於2022年1月24日按代價約3.14億港元出售合共約5707.62萬股份予陳楨平,有關股份佔本公吿日的已發行股份總數的約14%。公吿稱,陳楨平作為戰略性股東加入,將會利用其豐富的社會資源和經驗促進公司在大數據及人工智能相關產業的發展,以及推進公司的融資活動,給公司帶來價值。董事會認為,引入戰略性股東後,將會進一步完善公司的治理體系,形成更加均衡的治理架構,此舉符合公司及股東的長遠利益。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.